SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 1-U - Current Report Pursuant to Regulation A:
SEC Accession No. 0001214659-20-009621
Filing Date
2020-11-17
Accepted
2020-11-17 06:01:42
Documents
17
Period of Report
2020-11-17
Items
Item 9.1: Other Events

Document Format Files

Seq Description Document Type Size
1 r11162011u.htm 1-U 14178
2 EXHIBIT 1U-15.1 ex1u-15_1.htm EX1U-15 ADD EXHB 8166
3 EXHIBIT 1U-15.2 ex1u-15_2.htm EX1U-15 ADD EXHB 26654
4 GRAPHIC alzamendlogo_sm.jpg GRAPHIC 18173
5 GRAPHIC slide_01.jpg GRAPHIC 280971
6 GRAPHIC slide_02.jpg GRAPHIC 265493
7 GRAPHIC slide_03.jpg GRAPHIC 65289
8 GRAPHIC slide_04.jpg GRAPHIC 214429
9 GRAPHIC slide_05.jpg GRAPHIC 228290
10 GRAPHIC slide_06.jpg GRAPHIC 124772
11 GRAPHIC slide_07.jpg GRAPHIC 158707
12 GRAPHIC slide_08.jpg GRAPHIC 155997
13 GRAPHIC slide_09.jpg GRAPHIC 143055
14 GRAPHIC slide_10.jpg GRAPHIC 122575
15 GRAPHIC slide_11.jpg GRAPHIC 117445
16 GRAPHIC slide_12.jpg GRAPHIC 162418
17 GRAPHIC slide_13.jpg GRAPHIC 264653
  Complete submission text file 0001214659-20-009621.txt   3250217
Mailing Address 3802 SPECTRUM BLVD, SUITE C112C TAMPA FL 33612
Business Address 3802 SPECTRUM BLVD, SUITE C112C TAMPA FL 33612 844-722-6333
Alzamend Neuro, Inc. (Filer) CIK: 0001677077 (see all company filings)

IRS No.: 811822909 | State of Incorp.: DE | Fiscal Year End: 0430
Type: 1-U | Act: 33 | File No.: 24R-00058 | Film No.: 201319167
SIC: 2834 Pharmaceutical Preparations